CRSWNP Clinical Trials

8 recruitingLast updated: May 11, 2026

There are 8 actively recruiting crswnp clinical trials across 21 countries. Studies span Not Applicable, Phase 3. Top locations include Qingdao, Shandong, China, Chicago, Illinois, United States, Brussels, Belgium. Updated daily from ClinicalTrials.gov.


CRSWNP Trials at a Glance

8 actively recruiting trials for crswnp are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Qingdao, Chicago, and Brussels. Lead sponsors running crswnp studies include Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Eli Lilly and Company, and AstraZeneca.

Browse crswnp trials by phase

Treatments under study

About CRSWNP Clinical Trials

Looking for clinical trials for CRSWNP? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new CRSWNP trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about CRSWNP clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

AsthmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)
AstraZeneca110 enrolled9 locationsNCT07399665
Recruiting
Not Applicable

Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain140 enrolled1 locationNCT06776042
Recruiting
Phase 3

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eli Lilly and Company510 enrolled194 locationsNCT06338995
Recruiting
Not Applicable

Th Study Wants to Compare the Best Technique for Sinus Operation in CRSWNP

CRSWNP
Kafrelsheikh University40 enrolled1 locationNCT07368361
Recruiting
Not Applicable

Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
The Affiliated Hospital of Qingdao University353 enrolled1 locationNCT07125586
Recruiting
Phase 3

Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.246 enrolled60 locationsNCT07107256
Recruiting

Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.

Smell LossChronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
Northwestern University30 enrolled1 locationNCT06892704
Recruiting

Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)

Chronic Rhinosinusitis (CRS)Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Universitaire Ziekenhuizen KU Leuven300 enrolled8 locationsNCT06683261